Parr McKnight Wealth Management Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Parr McKnight Wealth Management Group's BMY Position: Q4 2025 in Review
Parr McKnight Wealth Management Group sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 5,550 shares — an estimated $250K sold.
Parr McKnight Wealth Management Group first reported a position in BMY in Q4 2024 and held it in 4 quarters. The position peaked at $338K in Q1 2025. 2,454 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- Parr McKnight Wealth Management Group reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
- Parr McKnight Wealth Management Group sold 5,550 Bristol-Myers Squibb shares in Q4 2025, an estimated $250K.
- Parr McKnight Wealth Management Group first reported a position in Bristol-Myers Squibb in Q4 2024 and held it in 4 quarters.
- Parr McKnight Wealth Management Group's Bristol-Myers Squibb position peaked at $338K in Q1 2025.
- 2,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on Parr McKnight Wealth Management Group's 13F filing for Q4 2025, filed 10 Feb 2026.